Literature DB >> 18292507

Constitutive expression of IL-7 receptor alpha does not support increased expansion or prevent contraction of antigen-specific CD4 or CD8 T cells following Listeria monocytogenes infection.

Jodie S Haring1, Xuefang Jing, Julie Bollenbacher-Reilley, Hai-Hui Xue, Warren J Leonard, John T Harty.   

Abstract

Expression of IL-7Ralpha (CD127) has been suggested as a major determinant in the survival of memory T cell precursors. We investigated whether constitutive expression of IL-7Ralpha on T cells increased expansion and/or decreased contraction of endogenous Ag-specific CD4 and CD8 T cells following infection with Listeria monocytogenes. The results indicate that constitutive expression of IL-7Ralpha alone was not enough to impart an expansion or survival advantage to CD8 T cells responding to infection, and did not increase memory CD8 T cell numbers over those observed in wild-type controls. Constitutive expression of IL-7Ralpha did allow for slightly prolonged expansion of Ag-specific CD4 T cells; however, it did not alter the contraction phase or protect against the waning of memory T cell numbers at later times after infection. Memory CD4 and CD8 T cells generated in IL-7Ralpha transgenic mice expanded similarly to wild-type T cells after secondary infection, and immunized IL-7Ralpha transgenic mice were fully protected against lethal bacterial challenge demonstrating that constitutive expression of IL-7Ralpha does not impair, or markedly improve memory/secondary effector T cell function. These results indicate that expression of IL-7Ralpha alone does not support increased survival of effector Ag-specific CD4 or CD8 T cells into the memory phase following bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292507     DOI: 10.4049/jimmunol.180.5.2855

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Plasticity in programming of effector and memory CD8 T-cell formation.

Authors:  Ramon Arens; Stephen P Schoenberger
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival.

Authors:  Timothy W Hand; Weiguo Cui; Yong Woo Jung; Esen Sefik; Nikhil S Joshi; Anmol Chandele; Ying Liu; Susan M Kaech
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

Review 3.  Generation, persistence and plasticity of CD4 T-cell memories.

Authors:  Jason R Lees; Donna L Farber
Journal:  Immunology       Date:  2010-05-10       Impact factor: 7.397

4.  STAT5 is critical to maintain effector CD8+ T cell responses.

Authors:  Pulak Tripathi; Sema Kurtulus; Sara Wojciechowski; Allyson Sholl; Kasper Hoebe; Suzanne C Morris; Fred D Finkelman; H Leighton Grimes; David A Hildeman
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

Review 5.  Intrinsic and extrinsic control of effector T cell survival and memory T cell development.

Authors:  Timothy W Hand; Susan M Kaech
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

6.  The precursors of memory: models and controversies.

Authors:  Rafi Ahmed; Michael J Bevan; Steven L Reiner; Douglas T Fearon
Journal:  Nat Rev Immunol       Date:  2009-08-14       Impact factor: 53.106

7.  The early generation of a heterogeneous CD4+ T cell response to Leishmania major.

Authors:  Sara L Colpitts; Phillip Scott
Journal:  J Immunol       Date:  2010-07-12       Impact factor: 5.422

8.  Opposing effects of TGF-beta and IL-15 cytokines control the number of short-lived effector CD8+ T cells.

Authors:  Shomyseh Sanjabi; Munir M Mosaheb; Richard A Flavell
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

Review 9.  Generation and maintenance of memory CD4(+) T Cells.

Authors:  Ester M M van Leeuwen; Jonathan Sprent; Charles D Surh
Journal:  Curr Opin Immunol       Date:  2009-03-11       Impact factor: 7.486

10.  Disparate roles for STAT5 in primary and secondary CTL responses.

Authors:  Diana M Mitchell; Matthew A Williams
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.